| Product Name | MF | CAS | Details |
|---|
| Etoricoxib Dimer Impurity | Details |
| (2-Amino-5-fluorophenyl)(phenyl)methanone | C13H10FNO | 362-46-9 | Details |
| 25-O-Deacetyl rifabutin | C44H60N4O10 | 100324-63-8 | Details |
| 2,8-Dimethyl-5-phenethyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole hydrochloride | C21H24N2*ClH | 1061354-48-0 | Details |
| 2-Methoxy-3-nitropyridine | C6H6N2O3 | 20265-35-4 | Details |
| 2-(Bromomethyl)-1-(propan-2-yl)piperidine hydrobromide | C9H19Br2N | 1803597-14-9 | Details |
| Sodium 2-(4-methoxypyridin-2-yl)acetate | C8H10NNaO3 | 1803561-74-1 | Details |
| Frovatriptan | C14H17N3O | 158747-02-5 | Details |
| H-EGYSGVGLLSR-OH | Details |
| 2-?Thiaspiro[3.3]?heptane-?6-?carboxylic acid 2,?2-?dioxide | C7H10O4S | 2092286-66-1 | Details |
| beta-Naphthonitrile | C11H7N | 613-46-7 | Details |
| Neotriptophenolide | C21H26O4 | 81827-74-9 | Details |
| 4-Mercaptomethyl dipicolinic acid | C8H7NO4S | 1040401-18-0 | Details |
| Sodium 5-bromo-4-methyl-1,3-thiazole-2-carboxylate | C5H3BrNNaO2S | 2138517-32-3 | Details |
| 6-Chloro-1,7-naphthyridin-4-ol | C8H5ClN2O | 1214241-98-1 | Details |
| Carthamus red | C43H42O22 | 36338-96-2 | Details |
| Methylphenidate-HRP | Details |
| 1-[(tert-butoxy)carbonyl]-1,2,3,6-tetrahydropyridine-4-carboxylic acid | C11H17NO4 | 70684-84-3 | Details |
| MASP2 antibody | Details |
| AChR alpha antibody | Details |
| Angiotensin II trifluoroacetate salt | C50H71N13O12 | 4474-91-3 | Details |
| TEC antibody | Details |
| Nfat transcription factor regulator-1 | C17H10F6N4O2 | 245747-71-1 | Details |
| (+/-)-2-Hydroxydecanoic acid | C10H20O3 | 5393-81-7 | Details |
| D-Tagatose-6-phosphate lithium salt | C6H13O9P | 73544-42-0 | Details |
| Methyl 2-amino-3-methoxypropanoate hydrochloride | C5H12ClNO3 | 88642-83-5 | Details |
| tert-butyl 3-(3-methoxyphenyl)piperazine-1-carboxylate | C16H24N2O3 | 886768-09-8 | Details |
| 6-Chloro-3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-8-amine | C6H6ClN5 | 53085-52-2 | Details |
| H-YQGFIFDIVTK^-OH | Details |
| 5-Bromo-4-chloro-2-(1-methylcyclopropyl)pyrimidine | C8H8BrClN2 | 1513097-54-5 | Details |
| C.I.Acid Orange 60 | C32H27CrN10O8S2 | 30112-70-0 | Details |
| (6-methylpiperidin-3-yl)methanol | C7H15NO | 278789-37-0 | Details |
| 2-(4-Aminophenoxy)-6-fluorobenzonitrile | C13H9FN2O | 1157011-71-6 | Details |
| Recombinant Human IL-20 | Details |
| 1-Methyl-3-[(3-methylbutan-2-yl)oxy]-1H-pyrazol-4-amine | C9H17N3O | 1698120-14-7 | Details |
| YM-46303 | C20H23ClN2O2 | 171722-81-9 | Details |
| 2,3,4,6-Tetra-O-acetyl-β-D-galactopyranosyl azide | C14H19N3O9 | 13992-26-2 | Details |
| 2-Methyl-5-phenyl-1,3-oxazole-4-carboxylic acid | C11H9NO3 | 91137-53-0 | Details |
| 7-Methylthieno[3,2-d]pyrimidine-2,4(1H,3H)-dione | C7H6N2O2S | 35265-81-7 | Details |
| 2-(N-Methyl4-chlorobenzenesulfonamido)acetic acid | C9H10ClNO4S | 59724-83-3 | Details |
| 1-N,2-N-Dimethyl-1-N-(1-methylpiperidin-4-yl)cyclohexane-1,2-diamine | C14H29N3 | 1306965-59-2 | Details |
| GATA1 antibody (Ser142) | Details |
| FSL-1 | C84H140N14O18S | 322455-70-9 | Details |
| SPACA1 antibody | Details |
| 5-Bromo-N-isopropyl-2-pyridinamine | C8H11BrN2 | 443339-43-3 | Details |
| 3-(Benzyloxy)-2,2-dimethylcyclobutan-1-amine | C13H19NO | 1518855-39-4 | Details |
| 6-Methoxy-3,5,7,4'-tetrahydroxyflavone | C16H12O7 | 32520-55-1 | Details |
| GFRA4 Blocking Peptide | Details |
| Ac-Lys-Gln-Leu-Arg-AFC trifluoroacetate salt | C35H51F3N10O8 | 1802078-38-1 | Details |
| 2-C-Methyl- 2, 3- O- isopropylidene - D- ribonic acid g- lactone | Details |
| 2-Methyl-3-[(3-methylphenyl)amino]propanenitrile | C11H14N2 | 1099681-88-5 | Details |
| 1-[(tert-butoxy)carbonyl]-4,4-difluoro-2-methylpyrrolidine-2-carboxylic acid | C11H17F2NO4 | 1447943-90-9 | Details |
| (5-Amino-2-ethoxyphenyl)methanol | C9H13NO2 | 647844-09-5 | Details |
| 2'-Deoxy-2'-fluorouridine | C9H11FN2O5 | 784-71-4 | Details |
| Sialyl Lewis X methyl glycoside sodium salt | C32H54N2O23 | 141612-87-5 | Details |
| PAX7 antibody | Details |
| 2-chloro-3-((2-fluorophenyl)amino)cyclohex-2-en-1-one | C12H11ClFNO | 1023496-35-6 | Details |
| 4,4'-Diacetyldiphenyl ether | C16H14O3 | 2615-11-4 | Details |
| 3-Fluoro-6-(methylamino)pyridine | C6H7FN2 | 868636-72-0 | Details |
| 3-{[(4-Oxo-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidin-2-yl)methyl]thio}propanoic acid | C14H16N2O3S2 | 790271-09-9 | Details |
| rac-2-[(3R,3aS,6aS)-5-{[(9H-Fluoren-9-yl)methoxy]carbonyl}-1,1-dioxo-hexahydro-2H-1λ6-thieno[2,3-c]pyrrol-3-yl]acetic acid | C23H23NO6S | 2137852-60-7 | Details |
| 3-(1H-Imidazol-1-ylmethyl)benzoic acid | C11H10N2O2 | 135611-31-3 | Details |
| Palmitoleoyl 3-carbacyclic phosphatidic acid | C20H37O5P | 910228-13-6 | Details |
| N'-Hydroxyoxane-3-carboximidamide | C6H12N2O2 | 1344851-08-6 | Details |
| 3-Chloro-6-fluoro-5-nitroisoquinoline | C9H4ClFN2O2 | 1841079-94-4 | Details |
| N-Methoxy-N-methyl-2-(oxolan-2-yl)acetamide | C8H15NO3 | 1496669-92-1 | Details |
| 2-Oxo clopidogrel (Mixture of Isomers) | C16H16ClNO3S | 109904-27-0 | Details |
| 1-{1-[(tert-Butoxy)carbonyl]piperidin-3-yl}-1H-1,2,3-triazole-5-carboxylic acid | C13H20N4O4 | 2091651-71-5 | Details |
| 3-Chloro-2,3-dihydro-1H-indol-2-one | C8H6ClNO | 68235-96-1 | Details |
| H-LALDNGGLAR-OH | Details |
| TNRC6B Blocking Peptide | Details |
| 4-Chloro-3-(methoxymethyl)aniline | C8H10ClNO | 1094675-66-7 | Details |
| Benzyl N-{[1-(hydroxymethyl)cyclopropyl]methyl}carbamate | C13H17NO3 | 1323557-45-4 | Details |
| α-Man-PEG3-Amine | C12H25NO8 | 353737-46-9 | Details |
| (S)-A-(Fmoc-amino)-4-hydroxybenzeneacetic acid | C23H19NO5 | 182883-41-6 | Details |
| Fmoc-Cys(Pam)2-OH | C53H83NO8S | 210532-98-2 | Details |
| CDw49d antibody | Details |
| [1-Ethyl-3-(trifluoromethyl)-1H-pyrazol-5-yl]methanol | C7H9F3N2O | 1173266-46-0 | Details |
| 4-Amino-N,N-dimethylpyrimidine-2-carboxamide | C7H10N4O | 1852216-34-2 | Details |
| LTB4R antibody | Details |
| 5-Cyanopyridine-2-sulfonyl fluoride | C6H3FN2O2S | 1934652-54-6 | Details |
| H-SYVPSAEQI-OH | Details |
| 4-Chloro-N,6-dimethyl-N-phenylpyrimidin-2-amine | C12H12ClN3 | 93669-68-2 | Details |
| (5-Bromo-7-methyl-1-benzofuran-2-yl)methanamine | C10H10BrNO | 1343809-80-2 | Details |
| NUDT16 antibody | Details |
| 3-[(2-Methylcyclopropyl)formamido]propanoic acid | C8H13NO3 | 926238-26-8 | Details |
| tert-Butyl 2-cyano-3,3-bis(ethylsulfanyl)prop-2-enoate | C12H19NO2S2 | 1955523-62-2 | Details |
| (2-Cyclopropylethyl)thiourea | C6H12N2S | 1467394-84-8 | Details |
| Spiro[2.4]heptan-1-amine hydrochloride | C7H14ClN | 17202-53-8 | Details |
| 4-Methyl-1H-indazol-3-ylamine | C8H9N3 | 1207529-96-1 | Details |
| 2-(5-bromo-1H-indol-1-yl)acetic acid | C10H8BrNO2 | 937621-97-1 | Details |
| 5-Ethylthiophene-2-sulfonamide | C6H9NO2S2 | 140646-34-0 | Details |
| 3-Bromo-1-(4-ethylphenyl)propan-1-one | C11H13BrO | 33994-10-4 | Details |
| TIMP-2 (145-168) (human, bovine) trifluoroacetate salt | Details |
| Recombinant Human CCL1 | Details |
| tert-Butyl 3-[(3-methylbut-2-en-1-yl)oxy]pyrrolidine-1-carboxylate | C14H25NO3 | 1384430-66-3 | Details |
| 3-Methoxycyclohexane-1-carbonyl chloride | C8H13ClO2 | 86571-80-4 | Details |
| OR5L1/2 antibody | Details |
| 4-(Difluoromethyl)-2-fluoropyridine | C6H4F3N | 84940-51-2 | Details |
| Clostridium difficile Toxin A Ab | Details |
| Product Total： Product Page： | ||||
| 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 | ||||